Focus Areas
Cause Selection
Global Health & Wellbeing
Effective Altruism (Global Health and Wellbeing)
Farm Animal Welfare
Global Aid Policy
Global Health & Development
Global Health R&D
Innovation Policy
Land Use Reform
Scientific Research
South Asian Air Quality
Longtermism
Biosecurity & Pandemic Preparedness
Effective Altruism Community Growth (Longtermism)
Potential Risks from Advanced AI
Other Areas
Criminal Justice Reform
History of Philanthropy
Immigration Policy
Macroeconomic Stabilization Policy
Grants
Research & Updates
Research Reports
Blog Posts
Notable Lessons
In the News
About Us
Grantmaking Process
How to Apply for Funding
Team
Contact Us
Stay Updated
We’re hiring!
Close menu
Focus Areas
Cause Selection
Global Health & Wellbeing
Effective Altruism (Global Health and Wellbeing)
Farm Animal Welfare
Global Aid Policy
Global Health & Development
Global Health R&D
Innovation Policy
Land Use Reform
Scientific Research
South Asian Air Quality
Longtermism
Biosecurity & Pandemic Preparedness
Effective Altruism Community Growth (Longtermism)
Potential Risks from Advanced AI
Other Areas
Criminal Justice Reform
History of Philanthropy
Immigration Policy
Macroeconomic Stabilization Policy
Grants
Research & Updates
Research Reports
Blog Posts
Notable Lessons
In the News
About Us
Grantmaking Process
How to Apply for Funding
Team
Contact Us
Stay Updated
We’re hiring!
Mobile Navigation Toggle
Stanford Medicine News Center: Jeffrey Glenn Granted $14.3 Million to Develop Broad Spectrum Drug
Portfolio Area: Science Supporting Biosecurity and Pandemic Preparedness
Focus Area: Scientific Research
Content Type: In the news
Table of Contents
Published: October 05, 2020
Back to Research & Updates
